David T. Rubin to Epidemiologic Methods
This is a "connection" page, showing publications David T. Rubin has written about Epidemiologic Methods.
Connection Strength
0.122
-
Randomised clinical trial: delayed-release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing--ASCEND I and II combined analysis. Aliment Pharmacol Ther. 2011 Mar; 33(6):672-8.
Score: 0.097
-
Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut. 2011 Jul; 60(7):937-43.
Score: 0.024